Deputy chief public health officer Dr. Howard Njoo responds to a question during a news conference, Tuesday, Jan. 12, 2021 in Ottawa. THE CANADIAN PRESS/Adrian Wyld

Deputy chief public health officer Dr. Howard Njoo responds to a question during a news conference, Tuesday, Jan. 12, 2021 in Ottawa. THE CANADIAN PRESS/Adrian Wyld

UPDATE: Data suggests Pfizer vaccine may be almost as good after 1 dose as 2

Pfizer to ship nearly three million doses over next six weeks, Moderna more than 1.4 million.

There is compelling evidence that a single dose of COVID-19 vaccines may provide almost as much protection as giving two doses, Canada’s deputy chief public health officer said Thursday.

Dr. Howard Njoo said the advisory committee of federal and provincial public health officers is having an active discussion about whether Canada would be better served to delay the second doses of vaccines in a bid to give protection to more vulnerable people quicker.

“These are what I would call early data in terms of a vaccine effectiveness or studies,” he said. “And the indications are that there’s a good level of protection after just one dose.”

Canada intends to vaccinate three million people with two doses by the end of March.

More than 990,000 Canadians have received at least one dose, and about one-third of those have also received their second doses.

RELATED: Senior homes stay safe as B.C. finds 427 more cases of COVID-19

RELATED: Two young adults from Cowichan Tribes have died of COVID-19

Quebec’s immunization committee went as far Thursday as to recommend nobody get a second dose until a first dose is injected into everyone in six high-risk groups, including people over 70, health-care workers, and people who live in long-term care homes and retirement residences.

The committee reported that single doses have been 80 per cent effective at preventing COVID-19 so far among long-term care residents and health workers who were vaccinated.

Questions about delaying the second doses arose almost as soon as vaccinations began in December, prompting a whirlwind of debate among scientists about the ethics of “going off label.”

Pfizer-BioNTech and Moderna’s vaccines — the two currently authorized in Canada — were tested by giving two doses, 21 days and 28 days apart respectively.

But Dr. Danuta Skowronski, the epidemiology lead for influenza and emerging respiratory pathogens at the British Columbia Centre for Disease Control, said data show two weeks after one dose of either vaccine, the protection against COVID-19 was almost as good as what was found after two doses.

Skowronski and Dr. Dr. Gaston De Serres from the Institut national de santé publique du Québec made the case in a letter published in the New England Journal of Medicine this week.

Moderna reported itself that two weeks after one dose, those who got the vaccine were 92 per cent less likely to develop COVID-19 symptoms.

Pfizer and BioNTech, whose vaccine uses similar genetic technology to Moderna’s, said their vaccine was 52 per cent effective after one dose, but 94.5 per cent effective after two.

Skowronski said Pfizer started measuring illness as soon as the injections were given, which she said is “unreasonable.”

“It’s basic vaccinology that you don’t expect the vaccine to activate the immune system instantaneously,” she said, in an interview with The Canadian Press.

Skowronski said if you wait two weeks to start counting infections, there were 92 per cent fewer infections of COVID-19 among those who got one dose of the vaccine, compared with those who got the placebo.

At that level of protection, she said “we need to get a first dose into our priority populations, and the most vulnerable of those at greatest risk of severe outcomes and the precious resource of our front-line health-care workers.”

She said the second dose should eventually be given but said there isn’t a maximum time she would put on how long to wait.

Pfizer has issued caution about adjusting the dosing schedule but said the decision to do so rests with local authorities.

“We at Pfizer believe that it is critical for health authorities to carry on surveillance on implemented alternative dosing schedules to ensure that vaccines provide the maximum possible protection,” the company’s statement reads.

Canada’s National Advisory Committee on Immunization said in January that the recommended schedule should be followed wherever possible but that delaying a second dose up to six weeks could be beneficial, particularly with a shortage of supplies and a fast-spreading virus.

Skowronski said waiting six weeks instead of three or four for a second dose won’t do much.

“That’s not maximizing coverage that we need to undertake with the scarcity of the vaccine that is available now.”

Several provinces have been delaying the second doses a couple of weeks, particularly as deliveries of both Pfizer-BioNTech’s vaccine and Moderna’s slowed to a crawl in mid-January.

Those delays appear to be over. Pfizer says it will ship nearly three million doses over the next six weeks, and Moderna promises to ship more than 1.4 million.

With the two authorized vaccines, and the two-dose schedule followed, Canada expects to vaccinate 14.5 million people by the end of June and all Canadians who want to be immunized by the end of September.

A new vaccination schedule issued Thursday shows if the other three vaccines currently being reviewed get approved by Health Canada, 24.5 million Canadians could be vaccinated before Canada Day.

Mia Rabson, The Canadian Press

Like us on Facebook and follow us on Twitter.

Want to support local journalism? Make a donation here.

Coronavirus

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

(Black Press file photo)
Blackfalds continuing its fight for a registries office

The Town of Blackfalds has been fighting for a Registry Service outlet for roughly a decade

Alberta Premier Jason Kenney said Thursday that the province may consider a regional approach to loosening COVID-19 restrictions if numbers continue to decline. (photo by Chris Schwarz/Government of Alberta)
Province further easing health restrictions

Numbers of people hospitalized and in intensive care has dropped dramatically, says premier

Eric Rajah, co-founder of A Better World. (Photo Submitted)
Two Lacombe residents recieve award from Governor General for chairty work

Eric Rajah and Brian Leavitt co-founded A Better World, a charity which started in Lacombe in 1990

A ” Justice for Jeff” T-shirt. (Photo submitted)
Rally to be held outside courthouse for man slain in Lacombe

Sentencing for accused charged with manslaughter with a firearm set for March 4 in Red Deer

File photo
Alberta’s central zone has 670 active cases

301 new cases identified Sunday

Bookings for COVID-19 vaccines for people age 75 or older start Wednesday. (File photo by THE CANADIAN PRESS)
Updated: Delays for seniors booking for vaccine appointments

By 9:20 a.m. Wednesday, 4,500 seniors had booked their appointments

Ryan Jake Applegarth of Ponoka, 28, is scheduled to appear at Ponoka Provincial Court on March 12, 2021. (File photo)
Discussions about justice continue as Ponoka murder victim’s case proceeds

Reaction to comments Ponoka Staff Sgt. Chris Smiley made to town council last month

Dr. Stanley Read
Hometown Bashaw doctor recognized with alumni award for AIDS work

Dr. Stanley Read, born and raised in Bashaw, is considered a global health leader

A copy of the book “And to Think That I Saw It on Mulberry Street,” by Dr. Seuss, rests in a chair, Monday, March 1, 2021, in Walpole, Mass. Dr. Seuss Enterprises, the business that preserves and protects the author and illustrator’s legacy, announced on his birthday, Tuesday, March 2, 2021, that it would cease publication of several children’s titles including “And to Think That I Saw It on Mulberry Street” and “If I Ran the Zoo,” because of insensitive and racist imagery. (AP Photo/Steven Senne)
6 Dr. Seuss books won’t be published for racist images

Books affected include McElligot’s Pool, On Beyond Zebra!, Scrambled Eggs Super! and The Cat’s Quizzer

AstraZeneca’s vaccine ready for use at the vaccination centre in Apolda, Germany, Sunday, Feb. 28, 2021. THE CANADIAN PRESS/Michael Reichel/dpa via AP
National panel advises against using Oxford-AstraZeneca’s COVID-19 vaccine on seniors

NACI panel said vaccines from Pfizer and Moderna are preferred for seniors ‘due to suggested superior efficacy’

Shipping containers are seen at the Fairview Cove Container Terminal in Halifax on Friday, Aug. 25, 2017. THE CANADIAN PRESS/Andrew Vaughan
Canadian economy contracted 5.4 per cent in 2020, worst year on record

Drop was largely due to shutdowns in the spring as COVID began to spread

THE CANADIAN PRESS/Jeff McIntosh
Time to check the mail: Every household to receive a Canada Post postcard this spring

Postcard can be mailed for free to any address in Canada

A cross-country skier glides along the banks of the Ottawa River in Ottawa on Thursday, Feb. 25, 2021. Canadians across the country can look forward to a mild spring peppered with the odd winter flashback throughout the first part of the season, according to predictions from one prominent national forecaster. THE CANADIAN PRESS/Sean Kilpatrick
Mild spring with some wintry blasts predicted for most of Canada: Weather Network

Weather Network is forecasting a slower than average start to spring in British Columbia

AstraZeneca’s vaccines are ready for use at the vaccination center in Apolda, Germany, Sunday, Feb.28, 2021. (Michael Reichel/dpa via AP)
Feds hoping for AstraZeneca shots this week as Pfizer-BioNTech prepare next delivery

The first of those doses could start to arrive in Canada as early as Wednesday

Most Read